EUVIMEDEUVIMED entdecken
Crossref

Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome

Robert Krysiak iD, Karolina Kowalcze, Bogusław Okopień

The Journal of Clinical Pharmacology · 2023

DOI: 10.1002/jcph.2268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2023. Verfasst von Robert Krysiak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance, Cardiovascular Diseases. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Women with polycystic ovary syndrome (PCOS), the most common endocrinopathy in reproductive age, are characterized by increased cardiometabolic risk. Similar hormonal and metabolic changes were found in their siblings. The purpose of our study was to compare blood pressure–lowering and pleiotropic effects of lisinopril between sisters of women with PCOS and their unrelated peers. The study included two age‐, body mass index–, and blood pressure–matched groups of women with grade 1 hypertension: 26 sisters of PCOS probands (Group 1) and 26 individuals without a family history of PCOS (Group 2), receiving 10–40 mg of lisinopril daily. Blood pressure, glucose homeostasis markers, plasma levels of lipids (androgens, estradiol, high‐sensitivity C‐reactive protein (hsCRP), homocysteine, fibrinogen, and uric acid), and urinary albumin‐to‐creatinine ratio (UACR) were measured before lisinopril treatment and 6 months later. At baseline, the study groups differed in insulin sensitivity, testosterone, free androgen index (FAI), hsCRP, homocysteine, and UACR. Blood pressure–lowering properties of lisinopril did not differ between the groups. The decrease in homocysteine and UACR, although observed in both groups, was stronger in Group 2 than in Group 1. Only in women without a family history of PCOS lisinopril improved insulin sensitivity and reduce hsCRP, fibrinogen, and uric acid. The remaining markers did not change throughout the study. Cardiometabolic effects of lisinopril correlated with testosterone, free androgen index, and changes in insulin sensitivity. The obtained results suggest that cardiometabolic effects of lisinopril may be slightly less pronounced in sisters of women with PCOS than in women without a family history of this disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInsulin ResistanceCardiovascular DiseasesFemaleHumansAndrogensLisinoprilC-Reactive ProteinSiblingsCardiometabolic Risk FactorsUric AcidTestosteroneFibrinogenBody Mass IndexRisk FactorsInsulin

Stichwörter der Autor:innen

angiotensin-converting enzyme inhibitorshypertensioninsulin sensitivitypleiotropic effectspolycystic ovary syndromerisk factors

Substanzen

AndrogensLisinoprilC-Reactive ProteinUric AcidTestosteroneFibrinogenInsulin

Autor:innen und Institutionen

  • Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.
  • Department of Pediatrics in Bytom, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.

ORCID-Profile: Robert Krysiak

Zitieren

APA

Krysiak, R., Kowalcze, K., & Okopień, B. (2023). Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2268

Vancouver

Krysiak R, Kowalcze K, Okopień B. Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome. The Journal of Clinical Pharmacology. 2023. doi:10.1002/jcph.2268

BibTeX
@article{Krysiak2023,
  author = {Krysiak, Robert and Kowalcze, Karolina and Okopień, Bogusław},
  title = {Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome},
  journal = {The Journal of Clinical Pharmacology},
  year = {2023},
  doi = {10.1002/jcph.2268}
}
Kostenlos starten →